Abstract
In Canada health care costs 127 billions dollars a year (direct costs $ 44 billion, indirect costs $ 83 billion). Of this, cardiovascular diseases (CVD), coronary heart disease (CHD) and stroke combined consume around 29.8 billion (10.9 billion direct & 18.9 billion indirect) dollars and remains as the number one cause of health burden[1].The direct cost refers to hospitalization (66%), drug costs (21%), Physicians fees (12%) and research (1%). Indirect costs refer to person years of lost life (premature death), disability costs and lost productivity.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Heart and Stroke Foundation of Canada. The changing face of heart disease and stroke in Canada 2000. Ottawa, Canada, 1999; pp 61–63.
The World Health Report 1997. Conquering suffering, Enriching humanity. Geneva, Switzerland, World Health Organization, 1997.
WHO Technical Report Series. No. 862, Hypertension Control. Report of a WHO Expert Committee. Geneva, Switzerland, World Health Organization, 1996.
Hypertension Detection and Follow-up Program Co-operative Group. Five-year findings of the Hypertension Detection and Follow-up Program: I. Reduction in mortality of persons with high blood pressure, including mild hypertension. J Am Med Assoc 1979; 242: 2562–2571.
Joffres MR, Ghadirian P, Fodor JG, et. al. Awareness, treatment, and control of hypertension in Canada. AJH 1997; 10: 1097–1102.
Campbell NRC, McKay DW. Accurate blood pressure measurement, why does it matter? Editorial. CMAJ. 1999;161:277–8.
Campbell, NRC, Myers MG, McKay DW Usual measurement of blood pressure. is it meaningful? Blood Pressure Monitoring 1999;4:71–6.
McKay DW, Campbell NRC, Parab LS, et. al. Clinical assessment of blood pressure. J Human Hypertens 1990; 4: 639–645.
Haynes BR, Lacourciere Y, Rabkin S, et. al. Report of the Canadian Hypertension Society Consensus Conference: 2. Diagnosis of hypertension in adults. Can Med Assoc J 1993; 149(4): 409–418.
Campbell, NRC, Myers MG, McKay DW Usual measurement of blood pressure. is it meaningful? Blood Pressure Monitoring 1999;4:71–6.
Abbot D, Campbell N, Carruthers-Czyzewski P, et. al. Canadian Coalition for High Blood Pressure Prevention and Control Guidelines for measurement of blood pressure, follow-up, and life-style counselling. Can J Pub Hlth 1994; 85 (Suppl. 2): S29–S35.
Collins R, Peto R, MacMahon S, et. al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827–838.
Bulpitt CJ. A risk-benefit analysis for treatment of hypertension. Postgrad Med J 1993; 69:764–774.
Rose G. Strategy of prevention. Lessons from cardiovascular disease. Br Med J 1981; 282: 18471851.
Rose G. Strategies of prevention: the individual and the population. InCoronary heart disease epidemiology. From aetiology to public health(eds.) Marmot M and Elliott P. Oxford University Press, Oxford, UK. 1994. Pp 311–324.
Cook NR, Cohen J, Hebert P, Taylor JO, Hennekens CH. Implications of small reductions in diastolic blood pressure for primary prevention. Arch Intern Med. 1995;155:701–9.
Nissinen A, Tuomilehto J, Salomaa V, Puska P. Hypertension Control. In The North Karelia Project. 20 years results and experiences (eds.) Puska P, Tuomilehto J, Nissinen A, Vartiainen E. The National Piblic Health Institute (KTL), Finland. 1995. Pp 95–105.
Salonen JT, Puska P, Kottke TE. Smoking, blood pressure and serum cholesterol as risk factors of acute myocardial infarction and death among men in Eastern Finland. Fur Heart J 1981; 2: 365373.
Tuomilehto J, Puska P, Tanskanen A, et. al. A community-based intervention study on the fesibility and effects of the reduction of salt intake in North Karelia, Finland. Acta Cardiol 1981; 36: 83–104.
Tuomilehto J, Puska P, Nissinen A, et. al. Community-based prevention of hypertension in North Karelia, Finland. Ann Clin Res 1984; 16 (Suppl. 43): 18–27.
Puska P, Iacono J, Nissinen A, et. al. Controlled, randomized trial of the effect of dietary fat on blood pressure. Lancet 1983; 1: 1–5.
Stamler J. Blood pressure and high blood pressure. Aspects of risk. Hypertension. 1991;18(suppl 1): 95–107.
Stamler J, Neaton JD, Wentworth DN. Blood pressure (systolic and diastolic) and risk of fatal coronary heart disease. Hypertension 1989;13(suppl I):2–12.
Chockalingam A, Bacher MCampbell NRCCutler H, Drover A, Feldman R, Fodor JG, Irving J, Ramsden V, Thivierge R, Tremblay G. Adherence to management of high blood pressure: Recommendations of the Canadian Coalition for High Blood Pressure Prevention and Control. Can J Publ Hlth 1998; 89(Suppl. I): 5–11.
Berlowitz DR, Ash AS, Hickey EC, Friedman RH, Glickman M, Kader B, Moskowitz MA. Inadequate management of blood pressure in a hypertensive population. NEJM 1998;339:1957–63.
Staeson WB. Opportunities to improve the cost-effectiveness of treatment for hypertension. Hypertension 1991; 18 (Suppl. I): 161–166.
Fletcher A. Pressure to treat and pressure to cost: a review of cost-effectiveness analysis. J Hypertens 1991; 9: 193–198.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Chockalingam, A., Campbell, N.R.C. (2001). Cost and Benefits of Blood Pressure Monitoring and Control. In: Angel, A., Dhalla, N., Pierce, G., Singal, P. (eds) Diabetes and Cardiovascular Disease. Advances in Experimental Medicine and Biology, vol 498. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1321-6_20
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1321-6_20
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5496-3
Online ISBN: 978-1-4615-1321-6
eBook Packages: Springer Book Archive